CClinicalTrials.gg
Status unknownNCT05693155Updated Feb 9, 2023

Experience of the Nationwide Gambling Self-exclusion Service Spelpaus - Effects and Limitations of a Unique Harm Reduction Instrument for Problem Gambling

An observational study in Gambling Disorder and Problem Gambling, sponsored by Region Skane. Status unknown at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-09.

Sponsored by Region Skane · Observational

The sponsor has not verified this record recently (last verified Feb 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
20
Ages
18 Years and older
Sex
All
01

Study summary

Qualitative interview study addressing the effects and limitations of a unique, government-based, nationwide self-exclusion service for the reduction of gambling-related harm. This service, which allows for individuals at risk of gambling problems (and for anyone) to self-exclude from all licensed gambling in the country, is unique in its nationwide, non-gambling-operator-dependent and multi-operator design. It is a promising tool for the prevention and harm reduction in relation to problem gambling and gambling disorder, but emerging research data report considerable limitations including high access to non-licensed gambling allowing users to breach the voluntary self-exclusion and relapse into hazardous gambling practices. This study will examine effects and limitations of the system, for gamblers and for concerned significant others of gamblers, through qualitative interviews addressing their experience of the system.

02

Conditions studied

  • Gambling Disorder
  • Problem Gambling

Browse trials for

Keywords

  • gambling disorder
  • problem gambling
  • concerned significant others
  • self-exclusion
  • harm reduction
03

In context

Gambling

147 studies on the registry are indexed under Gambling; 36 are open to participants now.

This study's planned enrollment of 20 is below the median of 268 across 21 observational studies indexed under Gambling.

Browse Gambling studies →

Lead sponsor

Region Skane is the lead sponsor of 372 studies on the registry; 113 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

  1. Patients at a gambling disorder unit, or self-recruited through social media advertising and defining as a person with a gambling problem
  2. Concerned significant others of patients at a gambling disorder unit or self-recruited through social media advertising and defining as a concerned significant other of a person with a gambling problem.

Inclusion criteria

  • Patient at a gambling disorder unit or self-recruited through social media advertising and defining as a person with a gambling problem, and/or concerned significant other of a patient at a gambling disorder unit or self-recruited through social media advertising and defining as a concerned significant other of a person with a gambling problem.

Exclusion criteria

Exclusion Criteria:

  • Inability to provide informed study consent and to carry out a qualitative research interview, due to language difficulties and/or cognitive problems.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • Individuals with a gambling problem

    Recruited from a gambling disorder treatment unit and/or from social media advertising addressing individuals with a gambling problem.

    Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')

  • Concerned significant others

    Recruited as concerned signifiant others of patients at a gambling disorder treatment unit and/or in social media advertising addressing concerned significant others of individuals with a gambling problem.

    Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')

Interventions

  • BehavioralVoluntary self-exclusion from gambling ('Spelpaus')

    Voluntary self-exclusion from gambling, using the government-based, official service 'Spelpaus' (literally 'play break')

06

What researchers measure

Primary outcomes

  1. Qualitative reporting of self-perceived effects from self-exclusion

    Subjective perception of favorable effects on gambling behavior or well-being

    Time frame: Since 2019

  2. Qualitative reporting of self-perceived harm or limitations from self-exclusion

    Subjective perception of negative impact or lack of improvement with respect to gambling behavior or well-being

    Time frame: Since 2019

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05693155
Lead sponsor
Region Skane
Collaborators
Lund University
Responsible party
Anders C Håkansson (Consultant physician, professor, Region Skane) — Principal investigator
First posted
Jan 20, 2023
Start date
Feb 13, 2023 (estimated)
Primary completion
Jun 30, 2023 (estimated)
Completion
Jul 31, 2024 (estimated)
Last update
Feb 9, 2023

Study contacts

Anders Håkansson, PhD
Contact
anders_c.hakansson@med.lu.se
+46 46 175596
Johanna Tjernberg, Reg Nurse
Contact
johanna.tjernberg@skane.se
+46 72 463 64 06
Anders Håkansson, PhD
principal investigator · Region Skåne
Helena Hansson, PhD
study director · Lund University, School of Social Work

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion